Table 6 Antibiotic susceptibility profile of Gram-positive bacteria isolated from newborn suspected of sepsis at Hawassa University Comprehensive specialized Hospital February 2021 to November 2021 (n = 35).

From: Bacterial etiology and risk factors among newborns suspected of sepsis at Hawassa, Ethiopia

Bacteria

Susceptibility profile n (%)

AMP

PEN

CN

E

CHL

VAN

OX (FOX)

LIN

SXT

CLN

CIP

 

Enterococcus Species (26)

R

26 (100)

24 (92.3)

ND

ND

2 (7.7)

8 (30.7)

ND

ND

ND

ND

ND

I

ND

ND

3 (11.5)

ND

ND

ND

ND

ND

S

2 (7.7)

ND

ND

21 (80.7)

18 (69.3)

ND

ND

ND

ND

ND

Staphylococcus aureus (9)

R

2 (22.2)

5 (55.6)

4 (44.4)

1 (11.1)

ND

ND

2 (22.2)

5 (55.6)

3 (33.3)

I

1 (11.1)

1 (11.1)

ND

ND

3 (33.3)

S

7 (77.77)

3 (33.3)

4 (44.4)

8 (88.9)

ND

ND

7 (77.8)

9 (100)

1 (11.1)

6 (66.7)

9 (100)

Total (35)

R

28 (80)

29 (82.9)

4 (44.5)

1 (11.1)

2 (7.7)

8 (30.8)

2 (22.2)

5 (55.6)

3 (33.3

I

1 (2.9)

1 (11.1)

3 (11.5)

3 (33.3)

S

7 (20)

5 (14.2)

4 (44.5)

8 (88.9)

21 (80.8)

18 (69.2)

7 (77.8)

9 (100)

1 (11.1)

6 (66.7)

9 (100)

  1. AMP Ampicillin, P Penicillin, CN Gentamicin, E Erythromycin, CLN Clindamycin, SXT sulfamethoxazole-trimethoprim, CIP Ciprofloxacin, OX Oxacillin, VAN Vancomycin, CHL Chloramphenicol, IN Linezolid, R Resistance, I Intermediate, S Susceptible, ND not determined.